Skip to main navigation
Skip to search
Skip to main content
Ben-Gurion University Research Portal Home
Help & FAQ
Link opens in a new tab
Search content at Ben-Gurion University Research Portal
Home
Profiles
Research output
Research units
Prizes
Press/Media
Student theses
Projects
Activities
Datasets
Research Labs
Pyridorin in type 2 diabetic nephropathy
Edmund J. Lewis
, Tom Greene
, Samuel Spitalewiz
, Samuel Blumenthal
, Tomas Berl
, Lawrence G. Hunsicker
, Marc A. Pohl
, Richard D. Rohde
, Itamar Raz
, Yair Yerushalmy
, Yoram Yagil
, Tommy Herskovits
, Robert C. Atkins
, Anne T. Reutens
, David K. Packham
, Julia B. Lewis
Barzilai University Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
137
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pyridorin in type 2 diabetic nephropathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Placebo
100%
Type 2 Diabetic Nephropathy
100%
Twice Daily
75%
Treatment Effect
50%
Serum Creatinine Concentration
50%
Randomized Placebo-controlled Trial
25%
Reactive Oxygen Species
25%
Diabetes Duration
25%
Carbonyl
25%
Analysis of Covariance
25%
Serum Creatinine
25%
Renal Impairment
25%
Baseline Serum Creatinine
25%
Lower Average
25%
Protein-to-creatinine Ratio
25%
Advanced Glycation End Products
25%
Renoprotective Effect
25%
Pyridoxamine
25%
Baseline Renal Function
25%
Medicine and Dentistry
Placebo
100%
Diabetic Nephropathy
100%
Creatinine
80%
Treatment Effect
40%
Diabetes
20%
Kidney Function
20%
Advanced Glycation End-Product
20%
Analysis of Covariance
20%
Reactive Oxygen Species
20%
Pyridoxamine
20%
Nursing and Health Professions
Placebo
100%
Diabetic Nephropathy
100%
Creatinine Blood Level
60%
Creatinine
20%
Analysis of Covariance
20%
Reactive Oxygen Metabolite
20%
Pyridoxamine
20%
Advanced Glycation End Product
20%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Diabetic Nephropathy
100%
Creatinine
80%
Reactive Oxygen Metabolite
20%
Advanced Glycation End Product
20%
Pyridoxamine
20%